Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1996;27:1328-1332

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Izumi, Y.
Right arrow Articles by Matsuo, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Izumi, Y.
Right arrow Articles by Matsuo, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBON DIOXIDE

(Stroke. 1996;27:1328-1332.)
© 1996 American Heart Association, Inc.


Articles

Effects of Defibrination on Hemorheology, Cerebral Blood Flow Velocity, and CO2 Reactivity During Hypocapnia in Normal Subjects

Yoshinari Izumi, MD; Yoshiyasu Tsuda, MD; Shin-Ichiro Ichihara, MD; Tsutomu Takahashi, MD Hirohide Matsuo, MD

the Second Department of Internal Medicine, Kagawa (Japan) Medical School.

Correspondence to Yoshinari Izumi, MD, Second Department of Internal Medicine, Kagawa Medical School, 1750-1 Ikenobe, Miki-Cho, Kagawa, 761-07 Japan. E-mail izumi@kms.ac.jp.

Background and Purpose Plasma fibrinogen is reported to be an independent risk factor for stroke and cardiovascular diseases. The effects of defibrination on hemorheology, middle cerebral artery (MCA) blood flow velocity, and CO2 reactivity during hypocapnia were evaluated in normal subjects.

Methods Twenty-five healthy subjects (mean age, 31.8±5.7 years) were included in the study. Measurements were done at rest and repeated 24 hours after administration of 10 batroxobin units. Plasma fibrinogen, plasma viscosity, and whole blood viscosity were measured as hemorheological factors. MCA blood flow velocity was measured with a transcranial Doppler flowmeter. Blood flow velocity was corrected to 40 mm Hg of end-tidal CO2 partial pressure (PETCO2), and expressed as CV40. CO2 reactivity was measured as percent change in mean blood flow velocity per millimeter of mercury PETCO2.

Results Plasma fibrinogen (from 7.04 to 2.29 µmol/L; P<.001), whole blood viscosity, and plasma viscosity decreased after administration of batroxobin. Mean MCA blood flow velocity at rest, CV40, and CO2 reactivity during hypocapnia increased significantly (from 67.4 to 73.6 cm/s, from 71.7 to 77.7 cm/s, and from 2.9%/mm Hg to 3.2%/mm Hg, respectively; P<.01) after defibrination. Mean arterial blood pressure and PETCO2 at rest were constant before and 24 hours after administration of batroxobin. There was a significant positive correlation between CV40 and CO2 reactivity (r=.623, P<.0001).

Conclusions The increase in MCA blood flow velocity was associated with improved CO2 reactivity and reduced blood viscosity after defibrination. The data may suggest that defibrination increases cerebral blood flow by reducing blood viscosity.


Key Words: carbon dioxide • cerebral blood flow • fibrinogen • rheology • ultrasonics




This article has been cited by other articles:


Home page
Arch NeurolHome page
H. Tomimoto, I. Akiguchi, R. Ohtani, H. Yagi, M. Kanda, H. Shibasaki, and Y. Yamamoto
The Coagulation-Fibrinolysis System in Patients With Leukoaraiosis and Binswanger Disease
Arch Neurol, October 1, 2001; 58(10): 1620 - 1625.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
H. Tomimoto, I. Akiguchi, H. Wakita, A. Osaki, M. Hayashi, and Y. Yamamoto
Coagulation Activation in Patients With Binswanger Disease
Arch Neurol, September 1, 1999; 56(9): 1104 - 1108.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. K. Pfefferkorn, H.-P. Knuppel, B. R. Jaeger, J. Thiery, and G. F. Hamann
Increased Cerebral CO2 Reactivity After Heparin-Mediated Extracorporal LDL Precipitation (HELP) in Patients With Coronary Heart Disease and Hyperlipidemia
Stroke, September 1, 1999; 30 (9): e1802 - 1806.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Kastrup, C. Thomas, C. Hartmann, and M. Schabet
Sex Dependency of Cerebrovascular CO2 Reactivity in Normal Subjects
Stroke, December 1, 1997; 28(12): 2353 - 2356.
[Abstract] [Full Text]